Several STING agonists, including 5, 6-dimethylxanthenone-4-acetic acid (DMXAA) and 10-carboxymethyl-9-acridanone (CMA), have been shown to possess anti-tumor activity and anti-pathogenic microbial properties (47). This evidence concerns the gene STING1 and neoplasm.